Irish blood cancer patient first to take part in drug trial

An Irish patient with blood cancer has become the first in the world to take part in a new drug trial which could pave the way for longer cancer remission times.

The man has started treatment for the blood cancer multiple myeloma. Patients with the condition normally respond poorly to standard treatment.

If successful, the new treatment could delay or prevent relapse which would mean blood cancer sufferers could have long remission periods. The patient is in Beaumont Hospital.